Compared with low/intermediate histologic grade ER+HER2− patients, grade III cases tended to have earlier age at diagnosis, larger tumors, greater risk of lymph node metastasis, and a higher chance of receiving chemotherapy. The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.